NZ504566A - The amorphous form of zafirulkast (Form A), a leukotriene antagonist, as a pharmaceutical composition in a multi-layered sustained release formulation for treatment of asthma and related conditions - Google Patents
The amorphous form of zafirulkast (Form A), a leukotriene antagonist, as a pharmaceutical composition in a multi-layered sustained release formulation for treatment of asthma and related conditionsInfo
- Publication number
- NZ504566A NZ504566A NZ504566A NZ50456698A NZ504566A NZ 504566 A NZ504566 A NZ 504566A NZ 504566 A NZ504566 A NZ 504566A NZ 50456698 A NZ50456698 A NZ 50456698A NZ 504566 A NZ504566 A NZ 504566A
- Authority
- NZ
- New Zealand
- Prior art keywords
- zafirulkast
- asthma
- leukotriene antagonist
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726735.5A GB9726735D0 (en) | 1997-12-18 | 1997-12-18 | Pharmaceutical compositions |
| PCT/GB1998/003765 WO1999032082A2 (en) | 1997-12-18 | 1998-12-15 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ504566A true NZ504566A (en) | 2002-10-25 |
Family
ID=10823809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ504566A NZ504566A (en) | 1997-12-18 | 1998-12-15 | The amorphous form of zafirulkast (Form A), a leukotriene antagonist, as a pharmaceutical composition in a multi-layered sustained release formulation for treatment of asthma and related conditions |
Country Status (30)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO319624B1 (no) | 2003-09-15 | 2005-09-05 | Trouw Internat Bv | Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr. |
| US20050113410A1 (en) * | 2003-11-03 | 2005-05-26 | Mark Tawa | Pharmaceutical salts of zafirlukast |
| DE102006006532B4 (de) * | 2006-02-10 | 2007-11-08 | Biogenerics Pharma Gmbh | Pharmazeutische Zubereitung |
| CA2684655A1 (en) * | 2007-03-26 | 2008-10-02 | Teikoku Seiyaku Co., Ltd. | Oral pharmaceutical preparation for colon-specific delivery |
| US20090012146A1 (en) * | 2007-07-02 | 2009-01-08 | Giridhar Reddy Buggana | Solubility-enhanced pharmaceutical compositions comprising zafirlukast |
| CA3052071A1 (en) | 2017-01-30 | 2018-08-02 | Western New England University | Thiol isomerases inhibitors and use thereof |
| CN107714694A (zh) * | 2017-11-01 | 2018-02-23 | 天津国际生物医药联合研究院 | 扎鲁司特在抗结核分枝杆菌感染中的应用 |
| EP4340828A1 (en) | 2021-05-19 | 2024-03-27 | Quercis Pharma AG | Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis |
| EP4518852A1 (en) | 2022-05-06 | 2025-03-12 | Quercis Pharma AG | Method for treating cancers and neurological diseases using quercetin-containing compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
| IL100091A (en) * | 1990-12-12 | 1998-08-16 | Zeneca Ltd | Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation |
| GB9027018D0 (en) * | 1990-12-12 | 1991-01-30 | Ici Plc | Heterocyclic compounds |
| GB9119001D0 (en) * | 1991-09-05 | 1991-10-23 | Ici Plc | Pharmaceutical agents |
-
1997
- 1997-12-18 GB GBGB9726735.5A patent/GB9726735D0/en not_active Ceased
-
1998
- 1998-12-15 US US09/581,612 patent/US6399104B1/en not_active Expired - Fee Related
- 1998-12-15 EP EP98960024A patent/EP1041966B1/en not_active Expired - Lifetime
- 1998-12-15 AU AU15711/99A patent/AU744326C/en not_active Ceased
- 1998-12-15 CA CA002313163A patent/CA2313163A1/en not_active Abandoned
- 1998-12-15 HU HU0004669A patent/HUP0004669A3/hu unknown
- 1998-12-15 UA UA2000074270A patent/UA62991C2/uk unknown
- 1998-12-15 DK DK98960024T patent/DK1041966T3/da active
- 1998-12-15 NZ NZ504566A patent/NZ504566A/xx unknown
- 1998-12-15 DE DE69816124T patent/DE69816124T2/de not_active Expired - Fee Related
- 1998-12-15 ES ES98960024T patent/ES2202915T3/es not_active Expired - Lifetime
- 1998-12-15 TR TR2000/01713T patent/TR200001713T2/xx unknown
- 1998-12-15 CN CN98812227A patent/CN1282244A/zh active Pending
- 1998-12-15 PT PT98960024T patent/PT1041966E/pt unknown
- 1998-12-15 KR KR1020007006598A patent/KR20010033206A/ko not_active Ceased
- 1998-12-15 RU RU2000119148/14A patent/RU2205006C2/ru not_active IP Right Cessation
- 1998-12-15 WO PCT/GB1998/003765 patent/WO1999032082A2/en not_active Application Discontinuation
- 1998-12-15 ZA ZA9811532A patent/ZA9811532B/xx unknown
- 1998-12-15 ID IDW20001070A patent/ID25857A/id unknown
- 1998-12-15 EE EEP200000330A patent/EE04260B1/xx not_active IP Right Cessation
- 1998-12-15 JP JP2000525077A patent/JP2001526206A/ja active Pending
- 1998-12-15 AT AT98960024T patent/ATE243999T1/de not_active IP Right Cessation
- 1998-12-15 BR BR9813666-6A patent/BR9813666A/pt not_active IP Right Cessation
- 1998-12-15 SK SK940-2000A patent/SK9402000A3/sk unknown
- 1998-12-15 IL IL13650198A patent/IL136501A0/xx unknown
- 1998-12-15 PL PL98341736A patent/PL341736A1/xx unknown
- 1998-12-17 MY MYPI98005718A patent/MY133096A/en unknown
- 1998-12-17 AR ARP980106440A patent/AR017884A1/es not_active Application Discontinuation
-
2000
- 2000-05-31 IN IN48MU2000D patent/IN191311B/en unknown
- 2000-06-16 NO NO20003141A patent/NO20003141D0/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2211284A1 (en) | Multiple unit sustained release dosage form | |
| IL142474A0 (en) | Pharmaceutical formulation comprising omeprazole | |
| CA2336570A1 (en) | Croscarmellose taste masking | |
| CA2290531A1 (en) | Pharmaceutical formulation of omeprazole | |
| CA2281420A1 (en) | Preparation of pharmaceutically-active granules | |
| ATE360412T1 (de) | Verfahren zur herstellung eines umhüllten geschmackmaskierten granulats mit sofortiger wirkstofffreisetzung | |
| SI0868912T1 (en) | Use of redispersible polymer powders or polymer granulates for coating pharmaceutical or agrochemical delivery forms | |
| KR910004180A (ko) | 저작성 약제학적 정제를 제조하기 위한 회전과립화 공정 및 맛을 은폐하기 위한 피복공정 | |
| CA2277913A1 (en) | New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof | |
| NZ504566A (en) | The amorphous form of zafirulkast (Form A), a leukotriene antagonist, as a pharmaceutical composition in a multi-layered sustained release formulation for treatment of asthma and related conditions | |
| CA2306103A1 (en) | Novel once-a-day controlled release sulfonylurea formulation | |
| CA2256751A1 (fr) | Comprime enrobe a base de maleate de trimebutine | |
| IL165211A0 (en) | Triggered start products and processes for the production and use thereof | |
| AU4764200A (en) | Granules containing a plant substance and method for producing the same | |
| GB2316086A (en) | Powder coating composition for electrostatic coating of pharmaceutical substrates | |
| ES2185452A1 (es) | Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion. | |
| AU2009315449B2 (en) | Novel method for preparing granulates of active principles, and granulates obtained thereof | |
| AUPO637197A0 (en) | Taste-masked pharmaceutical compositions | |
| US3446891A (en) | Encapsulated acacia syrup adhesive overlaid n-acetyl-p-aminophenol beadlet cores retaining thereon dextromethorphan,chlorpheniramine,and phenylephrine | |
| EP1149635A3 (en) | A process for the preparation of multi-layer coatings of the water-borne base coat/powder clear coat type | |
| RU2000119148A (ru) | Фармацевтические композиции | |
| JPH0714862B2 (ja) | 発泡浴剤 | |
| JPS5545601A (en) | Long-acting cephalexin and its preparation | |
| AU2001278804A1 (en) | 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients | |
| WO2003105811A3 (en) | PROGRESSIVE RELEASE COMPOSITIONS AND METHOD OF USE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| PSEA | Patent sealed |